Letters to the Editor
Consider Postural Orthostatic Tachycardia Syndrome in Patients with Syncope
Am Fam Physician. 2012 Sep 1;86(5):392-394.
Original Article: Evaluation of Syncope
Issue Date: September 15, 2011
Available at: http://www.aafp.org/afp/2011/0915/p640.html
to the editor: This article describes the assessment of patients who lose consciousness, understandably focusing on risk stratification. However, postural orthostatic tachycardia syndrome (POTS) was omitted in the differential diagnosis of syncope.
POTS was first characterized in 1993. It is a heterogeneous group of disorders sharing similar characteristics, and is diagnosed using the stand test or tilt-table test (see accompanying table1). POTS is thought to affect as many as 500,000 Americans. Although there is no evidence that persons with POTS experience a reduction in life expectancy, disability can be profound and equivalent to that of persons with heart failure and chronic obstructive pulmonary disease. Twenty-five percent of patients with POTS are unable to work.2
Table. Diagnostic Criteria for Postural Orthostatic Tachycardia Syndrome
Diagnostic Criteria for Postural Orthostatic Tachycardia Syndrome
Sustained heart rate increase of 30 bpm or more (40 bpm in persons 12 to 19 years of age) within 10 minutes of standing or head-up tilt in the absence of orthostatic hypotension
Standing heart rate often is 120 bpm or more within 10 minutes ofstanding or head-up tilt
Orthostatic tachycardia may be accompanied by symptoms of cerebral hypoperfusion and autonomic overactivity that are relieved by decumbency
Criteria not applicable for low resting heart rate
bpm = beats per minute.
Information from reference 1.
On standing, 500 mL of blood descends from the thorax. A normal autonomic nervous system adapts with immediate vasoconstriction; however, in persons with POTS, this mechanism fails and there is excessive pooling of blood. To compensate, there is an abnormal increase in heart rate (greater than 30 beats per minute) and catecholamine levels.2 Cerebral perfusion diminishes, but usually in the absence of hypotension.3
As a consequence of hypoperfusion, patients experience a multitude of symptoms, including syncope (30 to 41 percent), lightheadedness, palpitations, fatigue, headaches, mental clouding, exercise intolerance, anxiety, tremulousness, gastrointestinal upset, visual disturbance, and sweating.2,3 Symptoms are exacerbated by prolonged standing and sitting, heat, alcohol consumption, and rich meals. Because of these nonspecific symptoms, the condition is commonly misdiagnosed as anxiety, panic attacks, or chronic fatigue syndrome.
POTS tends to occur in persons 15 to 50 years of age, and is five times more common in women. Primary POTS may be of autoimmune or genetic etiology,4 and can occur after immunization, sepsis, or trauma, or during pregnancy. Secondary POTS may be caused by deconditioning, space flight, diabetes mellitus, poison ingestion, cancer, chemotherapy, joint hypermobility syndrome, and other connective tissue disorders.
Almost 90 percent of patients with POTS will respond to treatment.4 There is evidence that high fluid intake, graded exercise programs, support hosiery, and care with posture will improve symptoms.2 Pharmacologic treatments aim to increase blood volume and red blood cell mass (e.g., fludrocortisone, desmopressin, erythropoietin); vasoconstrict (e.g., midodrine, methylphenidate [Ritalin], octreotide [Sandostatin]); reduce heart rate (e.g., beta blockers); modify central neurovascular control (e.g., selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, clonidine [Catapres]); and facilitate neural transmission (e.g., pyridostigmine [Mestinon]).2,4
The author states that “approximately 20 to 50 percent of patients have unexplained syncope after diagnostic evaluation” and that “young patients who have frequent syncopal events, multiple vague symptoms, and no injury history should be screened for psychiatric disorders.” It would be prudent to consider POTS in this cohort of patients before recommending psychiatric evaluation.
1. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69–72.
2. Raj SR. The Postural Tachycardia Syndrome (POTS): pathophysiology, diagnosis & management. Indian Pacing Electrophysiol J. 2006;6(2):84–99.
3. Thieben MJ, Sandroni P, Sletten DM, et al. Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clin Proc. 2007;82(3):308–313.
4. Grubb B. Postural tachycardia syndrome. Circulation. 2008;117(21):2814–2817.
Send letters to Kenneth W. Lin, MD, MPH, Associate Deputy Editor for AFP Online, e-mail: email@example.com, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680.
Please include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the American Academy of Family Physicians permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
Copyright © 2012 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions